Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115758) titled 'The Efficacy and Safety of Tegileridine in Moderate to Severe Pain Management Following General Anesthesia in Elderly Total Hip Replacement Patients' on Dec. 30, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Huaihe Hospital of Henan University

Condition: Hip fracture

Intervention: Group Tegileridine:During induction of anesthesia, select sufentanil 0.3-0.4 µg/kg as the opioid analgesic, etomidate 0.3 mg/kg as the sedative, and rocuronium bromide 0.6 mg/kg as the muscle relaxant. During maintenance, remifentanil is selected as the opioid analgesic, with intermittent bol...